Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.
National Pharmacy Week is being celebrated every year in the last week of November to create awareness among the general public about the role of pharmacist in public health. The Geetanjali Institute of Pharmacy (GIP), Geetanjali University, Manwa Khera, Udaipur actively observed the National Pharmacy Week during 30th November, to 05th December, 2015 at the Geetanjali University campus. The theme of 54th National Pharmacy Week is ‘Responsible Use of Antibiotics Saves Lives’.
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) - India, Andhra Pradesh Regional Chapter head office at Raghavendra Institute of Pharmaceutical Education and Research – RIPER, in association with Indian Pharmaceutical Association (IPA) Anantapuramu Branch and Rural Development Trust (RDT) Hospitals Bathalapalli, Anantapuramu, Andhra Pradesh organized an One day “National Symposium on Exploring New Insights of Pharmacoeconomics and Outcome Research” on 5 December 2015 at RDT hospitals.
Indian Pharmaceutical Association (IPA) Anantapuramu Local Branch, with branch head office at Raghavendra Institute of Pharmaceutical Education and Research (RIPER), celebrated the National Pharmacy Week – 2015 from 1st–3rd December 2015.
A team of researchers led by the University of Georgia has identified several biological markers that make it possible to classify mental disorders with greater precision. The findings may lead to improved diagnostics and treatments for those suffering from mental illness.
[adsense:336x280:8701650588]
Children with allergic disease, particularly asthma and hay fever, have twice the rate of high blood pressure and high cholesterol, setting them on course for heart disease at early age, finds a new study.
Five in six women with increased risk of breast cancer turn down drugs that are likely to prevent the disease, finds cancer research scientists in Britain.
Researchers at the University of Warwick have worked with Coventry-based Medherant, a Warwick spinout company, to produce and patent the World’s first ever ibuprofen patch delivering the drug directly through skin to exactly where it is needed at a consistent dose rate.
Pfizer announced that the U.S. Food and Drug Administration (FDA) has approved QuilliChew ER chewable tablets. Pfizer now offers two different products for the treatment of ADHD in patients ages 6 years old and above – liquid Quillivant XR® (methylphenidate HCl) CII and new QuilliChew ER chewable tablets.
Unichem Laboratories has received final approval from the US health regulator to market generic Irbesartan tablets, used in treating hypertension, in the American market.
Takeda Pharmaceutical Company Limited announced results from the TOURMALINE-MM1 trial presented at the 57th Annual Meeting and Exposition of the American Society of Hematology (ASH), showing that treatment with NINLARO® (ixazomib) capsules is effective in extending progression free survival (PFS) with a manageable tolerability profile in patients with relapsed and/or refractory multiple myeloma. The TOURMALINE-MM1 trial is an international, randomized, double-blind, placebo-controlled Phase 3 clinical trial designed to evaluate once-weekly oral ixazomib plus lenalidomide and dexamethasone compared to placebo plus lenalidomide and dexamethasone.
CLICK HERE TO SUBSCRIBE,
PHARMATUTOR's DAILY EMAILS
Do Not Forget to Verify
(Click on Subscription link in your inbox)
--------
